ストックスクリーナーアプリを入手
4.67
1.74%
0.08
プレマーケット:
4.70
0.03
+0.64%
Ironwood Pharmaceuticals Inc (IRWD) 最新ニュース
Ironwood Pharmaceuticals (IRWD) price target increased by 28.97% to 7.04 - MSN
Ironwood Pharmaceuticals Inc expected to post earnings of 24 cents a shareEarnings Preview - TradingView
Ironwood Pharmaceuticals (IRWD) Highlights Provider Insights on TPN for SBS Treatment - GuruFocus
Why fewer TPN days matter: doctors cite infection, pain in short bowel syndrome - Stock Titan
MSN Money - MSN
Earnings Preview: IRWD to Report Financial Results Pre-market on May 07 - Moomoo
IRWD News | IRONWOOD PHARMACEUTICALS INC (NASDAQ:IRWD) - ChartMill
Press Release: Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update Call - Moomoo
Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update Call - ChartMill
IRWD Technical Analysis | Trend, Signals & Chart Patterns | IRONWOOD PHARMACEUTICALS INC (NASDAQ:IRWD) - ChartMill
Ironwood Pharmaceuticals (IRWD) Projected to Post Earnings on Wednesday - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 7.3%Here's What Happened - MarketBeat
[ARS] IRONWOOD PHARMACEUTICALS INC SEC Filing - Stock Titan
Ironwood (NASDAQ: IRWD) seeks 10M more equity plan shares in 2026 proxy - Stock Titan
Ironwood Pharmaceuticals (IRWD) price target increased by 10.31% to 5.46 - MSN
Book value per share of Ironwood Pharmaceuticals, Inc. Class A – SWB:I76 - TradingView
Bank of America (NASDAQ: IRWD) reports 6.1% stake in Ironwood Pharmaceuticals - Stock Titan
IRWD Price Today: Ironwood Pharmaceuticals, Inc.Stock Price, Quote & Chart | MEXC - MEXC Exchange
Ironwood (IRWD) to Present Landmark Survey Data at DDW 2026 - GuruFocus
Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutritio - PharmiWeb.com
Zacks Research Has Bearish Estimate for IRWD Q2 Earnings - MarketBeat
Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026 - Yahoo Finance
Zacks Research Issues Positive Outlook for IRWD Earnings - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 6%Here's What Happened - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Rating of "Hold" by Brokerages - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Short Interest Update - MarketBeat
Ironwood Pharmaceuticals (IRWD) Stock Put Call Ratio (Momentum Building) 2026-04-15Trading Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 7.8% HigherStill a Buy? - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap UpWhat's Next? - MarketBeat
Ironwood (IRWD) is one of the most attractive small-cap drug manufacturers, here is why - MSN
What events could move Ironwood Pharmaceuticals (IRWD) Stock next | Price at $3.58, Down 1.52%High Yield Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
New Highs: Is Ironwood Pharmaceuticals Inc affected by consumer sentimentM&A Rumor & Consistent Profit Alerts - baoquankhu1.vn
Is trend weakening for Ironwood Pharmaceuticals (IRWD) Stock | Price at $3.46, Down 1.98%Swing Signals - Cổng thông tin điện tử Tỉnh Sơn La
Breakout Move: Will Ironwood Pharmaceuticals Inc outperform the market in YEAR2026 Chart Watch & Intraday High Probability Setup Alerts - baoquankhu1.vn
Will Ironwood Pharmaceuticals (IRWD) Stock Miss Expectations | IRWD Q4 Earnings: Misses Estimates by $0.02Social Buy Zones - UBND thành phố Hải Phòng
Support Test: Does Ironwood Pharmaceuticals Inc have consistent dividend growth2026 EndofMonth & High Win Rate Trade Tips - baoquankhu1.vn
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Down 5.8%Time to Sell? - MarketBeat
0.67%
2.13%
大文字化:
|
ボリューム (24 時間):